LIN
Linde Plc
NASDAQ · Basic Materials · Chemicals - Specialty · GB
$524.74
+2.58%Year over year
Reported trailing growth
- Revenue
- +8.2%
- EBITDA
- +1.6%
- EBIT
- +3.5%
- EPS
- +0.9%
- Free cash flow
- +0.1%
- Operating cash flow
- +5.7%
Forward estimates
Based on analyst estimates
- Revenue
- +5.0%
- EBITDA
- +20.6%
- EPS
- +26.4%
Three-year CAGR
- Revenue
- +0.6%
- EBITDA
- +6.9%
- EBIT
- +12.7%
- Net income
- +18.5%
- EPS
- +20.9%
- Free cash flow
- -3.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026